All In Biotech

Drug Trial Radar · NCT04934683

The GUARDIAN Trial - Induction Agent Sub-Study

Tight Perioperative Blood Pressure Management to Reduce Serious Cardiovascular, Renal, and Cognitive Complications: The GUARDIAN Trial (Induction Agent Sub-Study Comparing Etomidate and Propofol)

Last checked: Nov 20, 2026Latest source record: Aug 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitationPivotal-lookingRandomized with 6,254 participants. This is a heuristic, not a regulatory label.

Status

Enrolling by invitation

Enrollment

6,254

Planned (sponsor's estimate)

Start

Jul 25, 2021

Primary completion

Dec 31, 2026

Study completion Apr 25, 2027

Sponsor

Lead sponsor
The University of Texas Health Science Center, HoustonAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 22, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Factorial
Masking
Double (participant, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a sub-study of the overall GUARDIAN trial (NCT04884802) in which some GUARDIAN trial participants will be additionally randomized to etomidate vs propofol for anesthetic induction.

Conditions

  • Major Surgery

Interventions

  • Routine Blood Pressure ManagementProcedure

    Routine blood pressure control.

  • Tight Blood Pressure ManagementProcedure

    Tight blood pressure control.

  • Etomidate InductionDrug

    Anesthetic induction with etomidate.

  • Propofol InductionDrug

    Anesthetic induction with propofol.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with a Composite of Major Perfusion-Related ComplicationsTime frame: During the initial 30 days after major non-cardiac surgery

Locations

11 sites in 4 countries. Site status is shown where the registry gives one.

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • MetroHealth Medical Center

    Cleveland, Ohio

  • Cleveland Clinic Fairview Hospital

    Cleveland, Ohio

  • Cleveland Clinic Main Campus

    Cleveland, Ohio

  • Beijing Shijitan Hospital, Capital Medical University

    Beijing, China

  • Peking Union Medical College Hospital

    Beijing, China

  • Shanghai Chest Hospital

    Shanghai, China

  • West China Hospital

    Sichuan, China

  • Shanghai Ninth People's Hospital

    Shanghai, Shanghai Municipality, China

  • University of Thessaly

    Larissa, Greece

  • National Defense College

    Tokyo, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.